Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study III (BLESSIII)
Clinical trial NCT03985982 · COMPLETED
Trial details
- NCT number
- NCT03985982
- Sponsor
- Croma-Pharma GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-29
- Primary completion
- 2019-12-04
- Enrollment
- 410
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.